Core Laboratories (NYSE:CLB – Get Free Report) is anticipated to announce its Q2 2026 results after the market closes on Wednesday, July 29th. Analysts expect Core Laboratories to announce earnings of $0.08 per share and revenue of $126.2580 million for the quarter. Core Laboratories has set its Q2 2026 guidance at 0.060-0.120 EPS. Interested persons may visit the the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Thursday, July 30, 2026 at 8:30 AM ET.
Core Laboratories (NYSE:CLB – Get Free Report) last posted its quarterly earnings data on Wednesday, April 29th. The oil and gas company reported $0.06 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.06. The business had revenue of $121.80 million during the quarter, compared to the consensus estimate of $122.99 million. Core Laboratories had a return on equity of 11.52% and a net margin of 5.94%.Core Laboratories’s quarterly revenue was down 1.4% on a year-over-year basis. During the same period in the prior year, the business posted $0.14 earnings per share. On average, analysts expect Core Laboratories to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Core Laboratories Stock Down 4.0%
Shares of NYSE:CLB opened at $11.20 on Tuesday. The firm has a market cap of $516.50 million, a P/E ratio of 17.24, a P/E/G ratio of 2.82 and a beta of 1.00. The company has a quick ratio of 1.50, a current ratio of 2.05 and a debt-to-equity ratio of 0.42. Core Laboratories has a 12-month low of $9.72 and a 12-month high of $20.36. The business has a fifty day simple moving average of $12.30 and a 200 day simple moving average of $15.44.
Core Laboratories Announces Dividend
Institutional Investors Weigh In On Core Laboratories
Several institutional investors and hedge funds have recently made changes to their positions in the business. Aster Capital Management DIFC Ltd bought a new stake in Core Laboratories in the fourth quarter worth approximately $34,000. Quarry LP boosted its holdings in shares of Core Laboratories by 118.1% during the 3rd quarter. Quarry LP now owns 2,953 shares of the oil and gas company’s stock worth $36,000 after buying an additional 1,599 shares in the last quarter. Tower Research Capital LLC TRC boosted its holdings in shares of Core Laboratories by 400.9% during the 2nd quarter. Tower Research Capital LLC TRC now owns 7,333 shares of the oil and gas company’s stock worth $84,000 after buying an additional 5,869 shares in the last quarter. Vestcor Inc acquired a new stake in shares of Core Laboratories during the 3rd quarter worth approximately $101,000. Finally, Mercer Global Advisors Inc. ADV acquired a new stake in shares of Core Laboratories during the 3rd quarter worth approximately $132,000. Institutional investors own 97.81% of the company’s stock.
Wall Street Analyst Weigh In
A number of research firms recently commented on CLB. Weiss Ratings lowered Core Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, June 24th. Wall Street Zen downgraded shares of Core Laboratories from a “hold” rating to a “sell” rating in a research report on Saturday, July 4th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Core Laboratories presently has an average rating of “Reduce”.
Get Our Latest Research Report on CLB
About Core Laboratories
Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.
The company’s portfolio spans two primary service lines: reservoir description and production enhancement.
Recommended Stories
- Five stocks we like better than Core Laboratories
- AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
- Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now
- Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There?
- Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
